Professional Documents
Culture Documents
VISION
Claris Presence
Integrated
Development, Life Saving Regulated Discovery Led/
Injectables
Manufacturing, Patented Brand & Support NDDS Markets Inventive
Marketing,
Supply
Contract Authourised
Development and Critical Care Semi-regulated/
and/or Formulations Inhalational & Developmental/
Branded & Orals Emerging Markets Innovative
Manufacturing Generic Support
Primary Generic
Outsourcing/ Un-regulated
Generic Healthcare APIs Ointments Product
Marketing/ Markets
& Formulation
Supply
OTC
3
Quick Facts
60+ products across therapies including anesthesia & analgesics, blood products,
anti-infectives, critical care, and nephrology
Key regulatory approvals: US FDA, MHRA (UK), TGA (Australia), GCC FDCA
Delivery systems: bags (PVC & NPVC), vials, ampoules, glass bottles
Manpower: 1,300+
All figures as on Dec 31, 2016 4
Global Footprint and Network
Manufacturing & Quality awards like IDMA and Frost & Sullivan IMEA
Manufacturing Technologies
o Large volume parenterals in glass bottles
o Emulsion manufacturing
o Bag manufacturing (PVC & Non-PVC)
7
Developmental Capabilities
8
Key Products
Paracetamol IV Linezolid
Bupivacaine Moxifloxacin
Midazolam
Lidocaine
9
9
Key Products (contd.)
Plasma Volume
Renal & Transplant Other Injectables
Expanders
10
10
Key Innovations
Propofol
Propofol MCT-LCT
o An advanced technology ensuring less pain
o Even suitable for children under 3 months
11
Key Innovations (contd.)
Iron Sucrose
12
Key Innovations (contd.)
Anti-infectives
Paracetamol IV
13
Branding & Promotion
Claris uses variety of branding & promotional tools to reinforce visibility in the market.
Indoor Branding Tools
o Creative promotional campaigns
o Plant visits by delegates
o Product launch campaigns
o Scientific literature
o Product brochures & leaflets
15
Way Ahead
Human Lives
16